%0 Journal Article
%T IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?
%A Laura C. Lighaam
%A Rob C. Aalberse
%A Theo Rispens
%J International Journal of Rheumatology
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/789164
%X Patients with autoimmune pancreatitis have a striking polyclonal elevation of total IgG4 in serum. This observation has been confirmed and extended to other fibrotic conditions (that are therefore called IgG4-related disease) but as yet remains unexplained. The affected tissue contains many IgG4-producing plasma cells embedded in a fibrotic matrix originating from activated mesenchymal (stellate) cells. We propose that the process results from an unusual interaction between two regulatory systems: the regulatory arm of the immune system (including Bregs) and the tissue repair regulatory components orchestrated by the activated stellate cell. This interaction results in ongoing mutual activation, generating TGFbeta, IL10, and vitamin D. This environment suppresses most immune reactions but stimulates the development of IgG4-producing plasma cells. 1. IgG4 Production in IRD IgG4-related disease (IRD, see Box 1) is a group of diseases with disparate symptoms, but sharing a common pathophysiology, which has only recently been recognized as a new disease entity [1]. IRD is characterized by massive infiltration of the affected organ by IgG4-positive plasma cells. This infiltration coincides with a disruption of the organization of the tissue and thus of tissue function. The extent of the plasmacytic tissue reaction in IRD is such that the first impression is often that of a tumor. While the prototypic site of IgG4 production in IRD is the pancreas, many other sites in the body can be involved, for example, the salivary and tear glands, reminding of Sj£¿gren¡¯s syndrome. However, in IRD, the ducts usually remain largely intact, and secretion by the glands is less severely affected [2]. It is not at all unusual to find several organs to be involved simultaneously (for details, see Box 1). Box 1: IgG4-related disease (IRD). A 5¨C50-time elevation of total IgG4 levels is found in patients with IRD. This results in a markedly increased IgG4/IgG ratio, both for serum immunoglobulin levels and for plasma cells in the affected tissue. It is not clear if the increased levels of IgG4 contribute to the pathology of IRD. So far, convincing support for the hypothesis that (auto-) antibody activity of IgG4 is driving the pathology is lacking. Several candidate autoantibodies have been suggested in IRD, such as antibodies directed against pancreatic trypsin inhibitor, lactoferrin, and carbonic anhydrase, mainly in patients with pancreatic involvement [3]. These antibodies were mostly not of the IgG4 subclass. Since they are present in only a small part of the patients, their
%U http://www.hindawi.com/journals/ijr/2012/789164/